(Q34201433)

31 July 2017

1 reference

title

The impact of drug-induced QT interval prolongation on drug discovery and development (English)

1 reference

31 July 2017

1 reference

Bernard Fermini

1

1 reference

31 July 2017

Anthony A Fossa

series ordinal

2

1 reference

31 July 2017

language of work or name

1 reference

1 June 2003

1 reference

Nature Reviews Drug Discovery

31 July 2017

published in

1 reference

31 July 2017

volume

2

1 reference

31 July 2017

issue

6

1 reference

31 July 2017

page(s)

439-447

1 reference

https://scigraph.springernature.com/pub.10.1038/nrd1108

31 July 2017

exact match

0 references

cites work

A plethora of mechanisms in the HERG-related long QT syndrome. Genetics meets electrophysiology

1 reference

Cellular mechanisms underlying the long QT syndrome.

31 March 2020

1 reference

Risks of non-sedating antihistamines

31 March 2020

1 reference

Torsade de pointes due to quinidine: observations in 31 patients

31 March 2020

1 reference

Pharmacokinetic and pharmacodynamic effects of high-dose continuous intravenous verapamil infusion: clinical experience in the intensive care unit

31 March 2020

1 reference

Verapamil-induced polymorphous ventricular tachycardia

31 March 2020

1 reference

Drug-induced prolongation of the QT interval: regulatory dilemmas and implications for approval and labelling of a new chemical entity

31 March 2020

1 reference

Cardiotoxic effect with convulsions in terfenadine overdose

31 March 2020

1 reference

HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine

31 March 2020

1 reference

A structural basis for drug-induced long QT syndrome

31 March 2020

1 reference

High throughput ion-channel pharmacology: planar-array-based voltage clamp

31 March 2020

1 reference

Identification of a specific radioligand for the cardiac rapidly activating delayed rectifier K+ channel

31 March 2020

1 reference

[3H]dofetilide binding in SHSY5Y and HEK293 cells expressing a HERG-like K+ channel?

31 March 2020

1 reference

Cell-based assays and instrumentation for screening ion-channel targets

31 March 2020

1 reference

The canine Purkinje fiber: an in vitro model system for acquired long QT syndrome and drug-induced arrhythmogenesis

31 March 2020

1 reference

Effects of sparfloxacin, grepafloxacin, moxifloxacin, and ciprofloxacin on cardiac action potential duration

31 March 2020

1 reference

Drugs that prolong QT interval as an unwanted effect: assessing their likelihood of inducing hazardous cardiac dysrhythmias

31 March 2020

1 reference

Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development

31 March 2020

1 reference

Inhibitory actions of the selective serotonin re-uptake inhibitor citalopram on HERG and ventricular L-type calcium currents

31 March 2020

1 reference

Fluoxetine-induced QTU interval prolongation, T wave alternans and syncope

31 March 2020

1 reference

Fluoxetine (Prozac) as a cause of QT prolongation

31 March 2020

1 reference

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRD1108

1 reference

Dimensions Publication ID

31 July 2017

1021233112

0 references

Fatcat ID

release_rihqgaatzveoxc3gksm54lr43e

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rihqgaatzveoxc3gksm54lr43e

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference